The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization-Reference-Cited by-同舟云学术

The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

Published:2017 Issue:3 Volume:6 Page:227-235
ISSN:2235-1795
Container-title:Liver Cancer
language:en
Short-container-title:Liver Cancer

Author:

Arizumi Tadaaki,Ueshima Kazuomi,Iwanishi Mina,Minami Tomohiro,Chishina Hirokazu,Kono Masashi,Takita Masahiro,Yada Norihisa,Hagiwara Satoru,Minami Yasunori,Ida Hiroshi,Komeda Yoriaki,Takenaka Mamoru,Sakurai Toshiharu,Watanabe Tomohiro,Nishida Naoshi,Kudo Masatoshi

Publisher

S. Karger AG

Subject

Oncology,Hepatology

Reference25 articles.

1. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.

2. Kudo M: Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. Liver Cancer 2015;4:39-50.

3. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, et al: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009;10:25-34.

4. Llovet JM, Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008;48:1312-1327.

5. Minami Y, Minami T, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, et al: Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma: a single-center experience. Oncology 2015;89(suppl 2):27-32.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Survival Using Whole-Liver MRI Radiomics in Patients with Hepatocellular Carcinoma After TACE Refractoriness;CardioVascular and Interventional Radiology;2024-05-15

2. Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma;Liver Cancer;2024

3. Intra-arterial delivery of doxorubicin-loaded hollow gold nanospheres—photothermal ablation and chemoembolisation therapy in a rabbit VX2 liver cancer model;Journal of Experimental Nanoscience;2022-06-25

4. GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial;Hepatology International;2022-01-04

5. STEAP3 promotes cancer cell proliferation by facilitating nuclear trafficking of EGFR to enhance RAC1-ERK-STAT3 signaling in hepatocellular carcinoma;Cell Death & Disease;2021-11